BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Neurocrine Biosciences, Inc. 

12790 El Camino Real

San Diego  California  92121  U.S.A.
Phone: 858-617-7600 Fax: 858-617-7601


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Neurocrine Biosciences, Inc. (NBIX) To Present At The 2014 Deutsche Bank (DB) Biofest And The 26th Annual Piper Jaffray Healthcare Conference 11/25/2014 11:56:37 AM
Neurocrine Biosciences, Inc. (NBIX) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 11/12/2014 8:01:44 AM
Neurocrine Biosciences, Inc. (NBIX) Announces Appointment Of Darin Lippoldt As Chief Legal Officer 11/4/2014 8:52:11 AM
Neurocrine Biosciences, Inc. (NBIX) To Present At The Nomura Biotechnology Conference 11/4/2014 8:22:39 AM
Neurocrine Biosciences, Inc. (NBIX) Reports Third Quarter 2014 Results 11/4/2014 8:10:52 AM
Neurocrine Biosciences, Inc. (NBIX) Receives Breakthrough Therapy Designation For NBI-98854 In Tardive Dyskinesia 10/30/2014 8:21:23 AM
Neurocrine Biosciences, Inc. (NBIX) Announces Conference Call And Webcast To Report Third Quarter 2014 Financial Results 10/28/2014 7:24:33 AM
Neurocrine Biosciences, Inc. (NBIX) Announces Initiation Of Phase 3 Study For VMAT2 Inhibitor NBI-98854 10/21/2014 7:15:07 AM
Neurocrine Biosciences, Inc. (NBIX) Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study 10/3/2014 7:17:03 AM
Neurocrine Biosciences, Inc. (NBIX) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/3/2014 4:08:05 PM
12345678910...